These results emphasize the potential of exercise as a therapeutic strategy for RP and highlight adiponectin as a promising target for future research aimed at elucidating the molecular pathways underlying retinal neuroprotection. This evidence concerns the gene ADIPOQ and retinitis pigmentosa 1.